Sexually Transmitted Infections (STIs) Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What Is the Forecasted Market Size and Growth Rate for the Sexually Transmitted Infections (STIs) Market?
The sexually transmitted infections (STIs) market has experienced rapid growth in recent years. It will grow from $63.69 billion in 2024 to $71.93 billion in 2025, at a CAGR of 12.9%. The growth is attributed to behavioral factors, educational and awareness campaigns, better healthcare access, and advancements in antibiotic development.

The sexually transmitted infections (STIs) market is expected to grow rapidly, reaching $113.38 billion by 2029, with a CAGR of 12.0%. The growth is driven by emerging STI strains, vaccination initiatives, telemedicine, at-home testing, and sexual health equity. Trends include the rise of antimicrobial resistance, the use of pre-exposure prophylaxis (PrEP), STI self-management, and enhanced sexual education.

What Factors Are Propelling the Expansion of the Sexually Transmitted Infections (STIs) Market?
The increasing implementation of government initiatives aimed at raising awareness of sexually transmitted infections (STIs) is expected to drive the growth of the sexually transmitted infections market. Government initiatives refer to programs or policies designed to address specific public health concerns. Various government-led efforts focus on STI prevention, control, and treatment, such as funding public education campaigns, offering vaccines for STI prevention, and providing low-cost or free screening and testing. For instance, in April 2023, Springfield-Greene County Health, a US-based public health department, introduced the Disease Intervention Specialist (DIS) program in collaboration with the Missouri Department of Health and Senior Services (Missouri DHSS) to address rising STI rates in Greene County. The initiative deploys specialists to contact individuals who test positive for syphilis or HIV, connect them with treatment options, and notify potentially exposed individuals. Therefore, the rise in government-led initiatives is fueling the growth of the sexually transmitted infections (STIs) market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp

Which Businesses Are at the Forefront of Sexually Transmitted Infections (STIs) Market Development?
Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

What Are the Latest Innovations in the Sexually Transmitted Infections (STIs) Market?
Leading companies in the sexually transmitted infections (STIs) market are investing in innovative products utilizing fluorescent PCR technology to gain a competitive edge. Fluorescent PCR is a molecular biology technique used to detect and quantify specific DNA sequences in biological samples. For example, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based molecular diagnostics company, launched two polymerase chain reaction (PCR) kits: the Mycoplasma Hominis Real-Time PCR Kit and the Treponema Pallidum Real-Time PCR Kit. These kits provide a complete PCR solution for early STI diagnosis. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit detects Mycoplasma hominis in male urethral swabs, female cervical or vaginal swabs, and urine samples, while the Treponema Pallidum Real-Time PCR Kit identifies Treponema pallidum nucleic acid in human serum and plasma.

How Is the Sexually Transmitted Infections (STIs) Market Segmented?
The sexually transmitted infections (STIs) market covered in this report is segmented -

1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types
2) By Treatment: Antibiotics, Antiviral
3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea
4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis
5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Where Is the Sexually Transmitted Infections (STIs) Market Growth Most Prominent?
North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Sexually Transmitted Infections (STIs) Global Market Report?

- Market Size Analysis: Analyze the Sexually Transmitted Infections (STIs) Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Sexually Transmitted Infections (STIs) Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Sexually Transmitted Infections (STIs) Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Sexually Transmitted Infections (STIs) Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13047

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.